Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

63
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
63
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

111
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
111
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

77
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
77
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benchmarking protein sequence and structure search methods for remote homology detection.

Genome biology·2026
Same author

BindRNAgen: Protein-binding RNA Sequence Generation Using Latent Diffusion Models.

Journal of molecular biology·2026
Same author

[Investigation of antidepressant active components and mechanisms of total triterpenoids of Wolfiporia cocos based on serum pharmacochemistry combined with network pharmacology and experimental validation].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

TransKla: A Local-Global Cross-Attention Based Transformer Approach for Prediction of Lysine Lactylation Sites.

Journal of chemical information and modeling·2026
Same author

DrugDL: dual-modal deep learning framework for multi-property drug prediction and targeted therapy discovery.

Bioinformatics (Oxford, England)·2026
Same author

Study on the thermal damage traces of common textile fibers after simulated transient thermal exposure in gas explosions.

Journal of forensic sciences·2026

Related Experiment Video

Updated: Mar 28, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

GPCR-drug interactions prediction using random forest with drug-association-matrix-based post-processing procedure.

Jun Hu1, Yang Li1, Jing-Yu Yang1

  • 1School of Computer Science and Engineering, Nanjing University of Science and Technology, Xiaolingwei 200, Nanjing 210094, China.

Computational Biology and Chemistry
|December 18, 2015
PubMed
Summary

A new computational tool, TargetGDrug, accurately predicts interactions between G-protein-coupled receptors (GPCRs) and drugs using sequence and molecular features. This method enhances drug discovery by improving prediction accuracy over existing tools.

Keywords:
Drug association matrixGPCR–drug interactionsMachine learningRandom forest

More Related Videos

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

23.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.8K

Related Experiment Videos

Last Updated: Mar 28, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

23.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.8K

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • G-protein-coupled receptors (GPCRs) are crucial targets for drug development.
  • Identifying GPCR-drug interactions is vital for drug discovery and understanding receptor function.

Purpose of the Study:

  • To develop a novel sequence-based predictor, TargetGDrug, for identifying GPCR-drug interactions.
  • To improve the accuracy of GPCR-drug interaction prediction.

Main Methods:

  • Integrated GPCR evolutionary sequence features with drug wavelet-based molecular fingerprints.
  • Employed a random forest (RF) classifier for initial prediction.
  • Utilized a drug-association-matrix-based post-processing step to refine predictions.

Main Results:

  • TargetGDrug demonstrated high efficacy on benchmark datasets.
  • Achieved a 15% improvement in Matthews correlation coefficient (MCC) compared to recent predictors.
  • Independent validation confirmed the method's predictive power.

Conclusions:

  • TargetGDrug offers an effective approach for predicting GPCR-drug interactions.
  • The tool has significant implications for accelerating drug discovery pipelines.
  • A webserver and datasets are available for academic research.